NUVAXOVID
NUVAXOVID
Approved
DIN Number
02543656
Drug Class
Human
Market Date
Dec 8, 2023
Company
HC
novavax inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02543656
AIG Number0163400001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BN04 COVID-19, PROTEIN SUBUNIT
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
SARS-COV-2 RECOMBINANT SPIKE PROTEINActive
Strength: 5 MCG / 0.5 ML
Monograph: SARS-COV-2 RECOMBINANT SPIKE PROTEIN